ACTIVE SESSION TAPE Equities Quant: AVOID NEW MONEY

Why Is BRVE (BRVE) Stock Up Today?

Updated Nov 22, 2026 7:42 AM ET ยท Prev Close $19.27

Pro Workspace
Last Session Price
$20.39 +5.81%
+$1.12 vs $19.27 prior close
Intraday Range
$18.82 โ€“ $21.16
Open $19.29
Relative Volume
1.67x Avg
866,495 sh
52-Week Range
$16.70 โ€“ $32.00
Benchmark Alpha
+9.45% vs SPY
+11.48% vs QQQ
20-Session Trend -6.8%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

BRVE Advancing 5.81% on 1.67x Relative Volume

Brve (Brve) is advancing 5.81% (+$1.12) to $20.39 on 1.67x average session volume. Relative to benchmarks, BRVE is outperforming the S&P 500 by +9.45%. 14-day RSI stands at 50.8, keeping momentum in a bullish regime.

NEWS 70% Weight
Where Does Braveheart Bio BRVE Value Sit After AHA Data?

Braveheart Bio has had a rough stretch on the market so far this year, and with the share price under pressure, the open question is how well that market value lines up with what the company currently shows on its balanc

TECHNICAL 68% Weight
Moving Average Structure: Mixed Alignment

Price ($20.39) trades relative to 20-day SMA ($20.16) and 50-day SMA ($21.23).

Volume Confirmation
HIGH VOLUME (1.67x) Accumulation
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

BRVE outperforming the S&P 500 by +9.45%
BRVE Session
+5.81%
$20.39
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Alpha vs SPY: +9.45% Alpha vs QQQ: +11.48%

Options Flow & Execution Desk

Recent BRVE Catalyst Headlines

Verified Wire
Where Does Braveheart Bio BRVE Value Sit After AHA Data?

Braveheart Bio has had a rough stretch on the market so far this year, and with the share price under pressure, the open question is how well that market value lines up with what the company currently shows on its balanc

Yahoo Finance ยท Nov 05, 2026
Braveheart Bio Brve , Why Is Attention Building Around It?

Braveheart Bio BRVE has drawn fresh attention after its clinical-stage focus on hypertrophic cardiomyopathy put its experimental cardiac myosin inhibitor programs in the spotlight for investors tracking specialized cardi

Yahoo Finance ยท Nov 04, 2026

1โ€“3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$19.27
Short-term support band
Upper Bound
$21.51
Short-term resistance band
Key Inflection Level
$20.16 (20-day SMA support)

Monitor volume expansion above 1.5x RVOL around $20.16 (20-day SMA support) for directional breakout confirmation.

Technical Regime (BRVE)

MIXED MA TREND
RSI (14)
50.8
Bullish
20-Day SMA
$20.16
Above 20d
50-Day SMA
$21.23
Below 50d
MACD Signal
Bullish
MACD -0.52
ADX (14)
18.2
Weak trend
10d Momentum
+1.79
Positive 10-day momentum

About BRVE

Sector
Equities

Get Instant BRVE Catalyst Alerts

Receive an email alert when BRVE triggers an unusual volume breakout, options sweep, or rating shift.

BRVE Session & Catalyst FAQ

Why is BRVE stock up today?

Brve (Brve) is advancing 5.81% (+$1.12) to $20.39 on 1.67x average session volume. Relative to benchmarks, BRVE is outperforming the S&P 500 by +9.45%. 14-day RSI stands at 50.8, keeping momentum in a bullish regime.

Is BRVE stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 1.67x relative volume (high participation). Our multi-factor model currently rates BRVE as AVOID NEW MONEY. Review full valuation, quality, and timing signals on the BRVE Buy or Sell Decision Brief โ†’

What is BRVE's intrinsic value and expected trading range?

At $20.39, BRVE's modeled 1-to-3 session range is $19.27 โ€“ $21.51, with a key inflection level at $20.16 (20-day SMA support). Compare current price against multi-year cash flow projections in the BRVE Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for BRVE?

RSI at 50.8 reflects constructive bullish momentum. BRVE trades at $20.39 relative to its 20-day SMA ($20.16) and 50-day SMA ($21.23), reflecting a mixed moving-average structure.

Tradestie Flagship Research & Market Hubs